We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EXAS market cap is 10.97B. The company's latest EPS is USD -1.1246 and P/E is -54.21.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 523.07M | 553M | 602.45M | 622.09M | 700.37M |
| Operating Income | -138.06M | -118.88M | -77.02M | -76.38M | 6.85M |
| Net Income | -148.76M | -127.75M | -74.15M | -81.03M | 794k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 876.29M | 1.49B | 1.77B | 2.08B | 2.58B |
| Operating Income | -233.78M | -791.68M | -855.68M | -593.51M | -214.39M |
| Net Income | -83.99M | -848.53M | -595.63M | -623.51M | -204.15M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.31B | 6.23B | 6.3B | 6.36B | 6.42B |
| Total Liabilities | 3.2B | 3.18B | 3.25B | 3.3B | 3.3B |
| Total Equity | 3.11B | 3.04B | 3.06B | 3.06B | 3.12B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.51B | 4.93B | 6.68B | 6.23B | 6.47B |
| Total Liabilities | 1.22B | 2.1B | 3.3B | 3.18B | 3.33B |
| Total Equity | 2.29B | 2.82B | 3.39B | 3.04B | 3.15B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -275.6M | -223.56M | -38.22M | 62.21M | 86.57M |
| Investing | 132.23M | 74.07M | 82.94M | 149.42M | 116.45M |
| Financing | 66.38M | 76.49M | 133.6M | 149.64M | 149.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -115.01M | 136.48M | -102.24M | -223.56M | 156.12M |
| Investing | -121.07M | -702.04M | -1.08B | 74.07M | 49.68M |
| Financing | 253.18M | 1.88B | 8.47M | 76.49M | 159.77M |
| Market Cap | 10.97B |
| Price to Earnings Ratio | -54.21 |
| Price to Sales Ratio | 4.29 |
| Price to Cash Ratio | 18.28 |
| Price to Book Ratio | 3.52 |
| Dividend Yield | - |
| Shares Outstanding | 181.53M |
| Average Volume (1 week) | 2.64M |
| Average Volume (1 Month) | 3.28M |
| 52 Week Change | -6.31% |
| 52 Week High | 100.77 |
| 52 Week Low | 56.05 |
| Spread (Intraday) | 1.46 (2.37%) |
| Company Name | EXACT Sciences Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.exactsciences.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
